Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and Stromectol 2*3 mg Tablets (Merck Sharp & Dohme B.V., Haarlem, The Netherlands)
Clinical trial NCT04854460 · COMPLETED
Trial details
- NCT number
- NCT04854460
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-28
- Primary completion
- 2021-02-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.